Pacific Biosciences of California (STU:P09) 3-Year Book Growth Rate : 14.50% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Pacific Biosciences of California 3-Year Book Growth Rate?

Pacific Biosciences of California's Book Value per Share for the quarter that ended in Mar. 2024 was €2.19.

During the past 12 months, Pacific Biosciences of California's average Book Value per Share Growth Rate was -14.00% per year. During the past 3 years, the average Book Value per Share Growth Rate was 14.50% per year. During the past 5 years, the average Book Value per Share Growth Rate was 43.80% per year. During the past 10 years, the average Book Value per Share Growth Rate was 13.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Pacific Biosciences of California was 90.60% per year. The lowest was -41.80% per year. And the median was -4.30% per year.

Competitive Comparison of Pacific Biosciences of California's 3-Year Book Growth Rate

For the Medical Devices subindustry, Pacific Biosciences of California's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pacific Biosciences of California's 3-Year Book Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pacific Biosciences of California's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Pacific Biosciences of California's 3-Year Book Growth Rate falls into.

Pacific Biosciences of California 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Pacific Biosciences of California (STU:P09) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Pacific Biosciences of California 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Pacific Biosciences of California's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Pacific Biosciences of California (STU:P09) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pacific Biosciences of California Inc (STU:P09) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

PACB:USA

Address

1305 O’Brien Drive, Menlo Park, CA, USA, 94025

Website

https://www.pacb.com

Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe.

Pacific Biosciences of California (STU:P09) Headlines

No Headlines